This information was published on 2025-04-08T14:06:59 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2531947 (IR 1845159) |
| (220) |
21 Jan 2025
|
| (300) |
CN, 08 Aug 2024, 80260226
|
| (500) |
The mark consists of the standard characters LYNCBIO without claim to any particulars color.
The applicant has advised that the words in the Mark have no meaning in English |
| (511) (510) |
Class 42
Technological research; research and development of new products for others; analysis of the mode of action of chemical combinations on animals; product quality testing; biochemical research and analysis; clinical trials; development of pharmaceutical preparations and medicines; pharmaceutical research and development; scientific research for medical purposes in the area of cancerous diseases; biomedical research; conducting early evaluation in the field of new pharmaceuticals; testing of pharmaceuticals. |
| (540) | LYNCBIO |
| (550) | Word |
| (730) |
LYNCBIO THERAPEUTICS CO., LTD.
|
Find out more about publications on the About page.